Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. billion, servicing nearly 340,000 active patients. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 to reach 3.2

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JULY 29, 2021

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Forward-looking statements.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

AUGUST 2, 2021

capital markets, negative global economic conditions, potential negative developments in our clinical trials or research programs, other negative developments in our business, or unfavorable legislative or regulatory developments. Any such forward-looking statements represent management’s estimates as of the date of this press release.

Clinical Trials 105

Clinical Trials Research and Development Treatment Conditions 105

Cannabis Law Report

OCTOBER 4, 2021

Total medical cannabis patients in Q3 increased to more than 9,600, up 32% from Q2 2021. 62% of the patients in Q3 were returning patients, up 35% from Q2 2021. ensuring uninterrupted supply for all Khiron patients. Year to date patient visits at Khiron clinics have exceeded 104,000, topping all patient visits in 2020.

Patients 52

Patients Events Treatment Agriculture 52

CannaTech

MAY 17, 2020

Rylie was scheduled to be with us in Tel Aviv, but with the event being delayed, we wanted to catch up with her and see how she’s doing and what initiatives she’s taken on since we saw her six months ago in Cape Town. It’s the kind of patient story that you never forget. She tackled a seemingly impossible job.

Oil 98

Oil Legislation Cannabis Patients 98

Cannabis Law Report

SEPTEMBER 22, 2022

Acting in one fell swoop, on September 18, 2022, California Governor Gavin Newsom signed 10 cannabis-related legislative bills into law. Below is a discussion of the cannabis-centric Senate and Assembly bills adopted during the 2022 Legislative session. SB 1186– Medicinal Cannabis Patients’ Right of Access Act.

Law 52

Law Events Packaging Pets 52

Cannabis Law Report

FEBRUARY 14, 2022

These ground-breaking treatments offer therapeutic access to either psilocybin (the active ingredient in ‘magic mushrooms’) or MDMA, a synthetic medicine. Remission rates range between 60-80% with no serious adverse events. Remission rates range between 60-80% with no serious adverse events.

Medicine 52

Medicine Access Therapy Treatment 52

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. The governor also signed Senate Bill 1700 to protect the privacy of doctors recommending low-THC marijuana and their patients.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. Forward-Looking Statements.

Therapy 76

Therapy Data Research and Development Events 76

Peninsula Alternative Health

DECEMBER 7, 2017

Whether you’re a new patient looking for medical advice or a curious mind who loves cannabis entertainment, blogs are a great source to start your medical marijuana journey. Her vision is to help patients and debunk stigma by featuring stories from patients who use cannabis to treat serious medical conditions. CannaEffect.

Digestion 68

Digestion Strains Patients Dispensary 68

Cannabis Law Report

OCTOBER 17, 2019

The introduction of these protocols will take the form of clinical trials and research that will include the usage of specific strains of cannabis that aid in chronic pain and cancer treatments. A key facet in this partnership will be work with the indigenous communities in Jamaica to identify the above mentioned strains.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

Cannabis Law Report

MARCH 6, 2019

Many observers are optimistic about legislative action later this year. The list of applicable medical conditions was expanded and other restrictions relaxed, resulting in an immediate surge in new patients enrolling for treatment. The Background. What’s New?

Legislation 45

Legislation Recreational Cannabis Events 45

Peninsula Alternative Health

DECEMBER 7, 2017

Whether you’re a new patient looking for medical advice or a curious mind who loves cannabis entertainment, blogs are a great source to start your medical marijuana journey. Her vision is to help patients and debunk stigma by featuring stories from patients who use cannabis to treat serious medical conditions. CannaEffect.

Digestion 40

Digestion Strains Patients Dispensary 40

Cannabis Law Report

JANUARY 9, 2019

Here’s the full report… First founded in 2017, the Caucus has been a pivotal element in our ability to build broad bipartisan support for legislation that would address every aspect of reform, from ending criminalization to research to veterans healthcare. Report NORML. A longtime champion of reform efforts, Rep.

Legislation 49

Legislation Policy Programs Cannabis 49

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). Case Context.

DEA 52

DEA Clinical Trials Policy Research and Development 52

SpeedWeed

JULY 31, 2021

Recognizing cannabis as a treatment to ease HIV/AIDS symptoms is uncommon in Mexico. Knowing how well cannabis and HIV/AIDS activists have worked together in history, it begs the question: Could a synergistic union between HIV/AIDS patients and cannabis activists in Mexico serve to push forward national medical marijuana legislation?

Medicine 52

Medicine Patients Access Research and Development 52

Cannabis Law Report

AUGUST 19, 2021

Under the licensing agreements, Cookies will also have a “Cookies Corner,” a store-within-a-store concept, at all of TerrAscend’s Apothecarium Alternative Treatment Centers in New Jersey. The licensing agreements are subject to regulatory approval. The statements in this press release are made as of the date of this release.

Cultivation 105

Cultivation Seed-To-Sale Conditions Business 105

Cannabis Law Report

FEBRUARY 18, 2020

Even though 47 states have legalized cannabis for some forms of medical use , New York significantly falls behind its neighbors in terms of marijuana legislation. History of Marijuana Legislation in New York. Marijuana legislation main driving forces. La Guardia – the mayor of NYC from 1934 to 1945. Age requirements.

Marijuana 59

Marijuana Consumption Dispensary Vaping 59

Sensi Seeds

NOVEMBER 21, 2018

Anyone who dares to cobble together a growbox inside their home and fill it with cannabis plants will be evicted in the event of an unplanned visit. Here, the drug legislation actually protects small home growers from criminal prosecution. Growers in Spain are in a better position. The situation is rather different in Spain.

Consumption 69

Consumption Cultivation Seed-To-Sale Cannabis 69

CannaMD

DECEMBER 9, 2020

Noting that the effects of oral administration of cannabis (edibles) can be less predictable that smoked or vaporized administration of products with similar levels of specific cannabinoids, the AHA cautions: Patients must be made aware that the onset of effects begins within 30 minutes to ?1

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Cannabis Law Report

MAY 28, 2019

Veterans are increasingly underrepresented in the legislative decision-making progress. Many patients with PTSD report having flashbacks or intrusive thoughts which result in involuntarily re-living past traumatic events. VHA treatment may require blood testing and urinalysis which can reveal marijuana use.

Access 49

Access Marijuana Research and Development Programs 49

Puff Puff Post

SEPTEMBER 24, 2019

Cannabis was a popular medical aid for patients suffering from rheumatic diseases and to help alleviate nausea. . It was not until the 1990’s that the government felt the pressure of thousands of medical patients advocating and fighting for the use of cannabis.

History 94

History Cannabinoids Indica Tincture 94

Cannabis Law Report

JULY 18, 2019

In the Kelly case, the Court held the state of California cannot, through the legislative process, impose a state limit on medical cannabis that is more restrictive than what is allowed under Proposition 215. BCC has direct oversight responsibility for retail and transportation only dispensaries, distributors, and cannabis event organizers.

Cultivation 64

Cultivation Environment Cannabis Agriculture 64

Freedom Leaf

JANUARY 4, 2018

I continue to advocate for patient access to medical marijuana, and work with recreational legalization groups like Start SMART New York and Drug Policy Alliance that aim to take away one of the many tools law enforcement uses to lock up people of color, and to make sure we’re not pushed out of this industry. ” QUEEN ADESUYI.

Data 60

Data Policy Media Cannabis 60

Cannabis Law Report

OCTOBER 24, 2019

nally, regulatory issues related to cannabis regarding age restrictions, legislative framework and other issues. Politicians are listening closely to the public discussions and consultations being raised at Cannabis educational events about how to move forward. Already, hundreds of patients in Curaçao use Cannabidiol (CBD) oil.

Law 45

Law Medicine Decriminalization Oil 45

Cannabis Law Report

SEPTEMBER 20, 2019

They write… In this week’s edition: Plans to vote on cannabis banking legislation announced in both chambers of Congress, with predictions that House will pass the SAFE Act by the end of October. House Majority Leader Steny Hoyer (D) intends to put the cannabis banking legislation on the floor by the end of September.

Vaping 40

Vaping Banking Research and Development DEA 40

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Additionally, there were several instances in which cepharanthine displayed growth inhibition which was comparable or superior to current gold standard treatments, including colorectal, liver and skin cancers.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “Patient referrals and training requests from our physician colleagues have increased by more than 500 per cent over the last year,” says Dr. .

Programs 108

Programs Research and Development Education Treatment 108

The Cannigma

MAY 7, 2021

There were somewhat of a, I want to say grey, but it wasn’t the pharma routes for patients in the US who wanted to get certain products, you know? What do those more pharmaceutical standards mean for patients? You know, you can’t isolate it in the same manner in order to reproduce and manufacture a certain product.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

DECEMBER 9, 2021

All securities issued in connection with the Financing will be subject to a statutory hold period expiring in accordance with applicable securities legislation. The study involved 100 treatment-resistant patients and were randomized to psilocybin or the nicotine patch, each receiving the same cognitive-behavioral therapy.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. Relevant AAFP Policy. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “Patient referrals and training requests from our physician colleagues have increased by more than 500 per cent over the last year,” says Dr. .

Programs 40

Programs Research and Development Education Treatment 40

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 12, 2019

The scheme allows patients and doctors to access a legal domestic source of cannabis for medicinal use. The introduction of new legislation in Queensland (revoking the Public Health (Medicinal Cannabis) Act 2016 (Qld)) to simplify the process for patients and doctors to access medicinal cannabis. Key Developments.

Medicine 40

Medicine Research and Development Cultivation Legislation 40

Cannabis Law Report

DECEMBER 5, 2021

Last year, the US House of Representatives passed legislation to remove cannabis (marijuana) from the CSA. Currently, legislation is being considered to decriminalize marijuana and establish a tax on sales similar to alcohol. American’s attitude and US law have come a long way since then.

Law 52

Law Marijuana Research and Development Recreational 52